PharmaKnowl Consulting proudly participated as an exhibitor at the 24th International Society of Pharmacovigilance (ISoP) Annual Meeting, held from 24–27 October 2025 at the InterContinental Cairo Semiramis, Cairo, Egypt.

Our team welcomed delegates and connected with pharmacovigilance professionals, regulatory authorities, pharmaceutical companies, researchers, and healthcare experts from around the world. The event provided an excellent platform for exchanging knowledge, discussing evolving regulatory expectations, and strengthening international collaborations in drug safety and patient care.

Recognized as one of the leading global conferences dedicated to pharmacovigilance and patient safety, the ISoP Annual Meeting brought together experts to explore the latest developments in drug safety science, signal detection, risk management, real-world evidence, artificial intelligence in pharmacovigilance, and the evolving global regulatory landscape.

Throughout the exhibition, the PharmaKnowl team showcased our comprehensive regulatory and pharmacovigilance services, including end-to-end pharmacovigilance solutions aligned with SFDA and international requirements, as well as our clinical and quality consulting services that help pharmaceutical and biotechnology companies achieve regulatory compliance with confidence.

The event also provided valuable opportunities to engage with industry leaders, exchange practical experiences, and explore new partnerships that support innovation and patient safety across the global life sciences sector.

Our participation in the 24th ISoP Annual Meeting reflects PharmaKnowl Consulting’s ongoing commitment to remaining at the forefront of global pharmacovigilance developments while strengthening international relationships that enable us to deliver high-quality regulatory and drug safety solutions to clients across Saudi Arabia, the GCC, and beyond.